Civic Intelligence

Bioadvance DBA the Biotechnology Greenhouse of Southeastern Pennsylvania

990 • Fiscal year 2024 • EIN 46-0481876

Jul 01, 2023 to Jun 30, 2024 • Filed on Apr 22, 2025

Organization ProfileWWW.BIOADVANCE.COM

View Organization Page

101 West Elm Street 330Conshohocken, PA 19428

(610) 230-0536

Siviq Scores

Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.

Liabilities / Assets

21st percentile

0.04x

Higher debt load relative to assets than 21% of similar nonprofits.

2024 filings • 501(c)3 • $50M-$100M nonprofits • Source year 2024

Liabilities / Revenue

58th percentile

0.47x

Higher debt load relative to revenue than 58% of similar nonprofits.

2024 filings • 501(c)3 • $50M-$100M nonprofits • Source year 2024

Net Margin

93rd percentile

63%

Higher net margin than 93% of similar nonprofits.

2024 filings • 501(c)3 • $50M-$100M nonprofits • Source year 2024

Top Officer Pay

58th percentile

$405,243

Higher top officer pay than 58% of similar nonprofits.

Top officer pay equals 5.7% of source-year revenue.

2024 filings • 501(c)3 • $50M-$100M nonprofits • Source year 2024

Asset Growth

22nd percentile

-1.0%

Faster asset growth than 22% of similar nonprofits.

2024 filings • 501(c)3 • $50M-$100M nonprofits • Annualized from 2023 to 2024

Revenue Growth

98th percentile

349%

Faster revenue growth than 98% of similar nonprofits.

2024 filings • 501(c)3 • $50M-$100M nonprofits • Annualized from 2023 to 2024

Balance Sheet
Liabilities / Assets21st percentile

Assets

Down

$81,128,530

Down $820,027 (-1.0%) from 2023

Net Assets

Up

$77,781,056

Up $438,179 (+0.6%) from 2023

Liabilities

Down

$3,347,474

Down $1,258,206 (-27%) from 2023

Revenue And Expenses
Liabilities / Revenue58th percentileNet Margin93rd percentile

Revenue

Up

$7,128,753

Up $5,542,461 (+349%) from 2023

Expenses

Up

$2,624,935

Up $116,416 (+4.6%) from 2023

Net Income

Up

$4,503,818

Up $5,426,045 (+588%) from 2023

Historical Trend

Balance Sheet Trend

Asset Growth22nd percentile

The highlighted filing sits inside the broader history for assets, liabilities, and net assets.

$100M$50M$0Assets 2010: $27,741,940Liabilities 2010: $477,969Net Assets 2010: $27,263,9712010Assets 2011: $27,011,673Liabilities 2011: $364,805Net Assets 2011: $26,646,8682011Assets 2012: $25,630,285Liabilities 2012: $540,305Net Assets 2012: $25,089,9802012Assets 2013: $26,647,958Liabilities 2013: $322,982Net Assets 2013: $26,324,9762013Assets 2014: $31,553,912Liabilities 2014: $465,297Net Assets 2014: $31,088,6152014Assets 2015: $28,978,459Liabilities 2015: $276,446Net Assets 2015: $28,702,0132015Assets 2016: $61,373,001Liabilities 2016: $614,234Net Assets 2016: $60,758,7672016Assets 2017: $60,962,570Liabilities 2017: $608,169Net Assets 2017: $60,354,4012017Assets 2018: $60,326,743Liabilities 2018: $637,973Net Assets 2018: $59,688,7702018Assets 2019: $66,045,472Liabilities 2019: $611,198Net Assets 2019: $65,434,2742019Assets 2020: $78,551,910Liabilities 2020: $650,521Net Assets 2020: $77,901,3892020Assets 2021: $80,190,811Liabilities 2021: $424,660Net Assets 2021: $79,766,1512021Assets 2022: $73,104,917Liabilities 2022: $301,566Net Assets 2022: $72,803,3512022Assets 2023: $81,948,557Liabilities 2023: $4,605,680Net Assets 2023: $77,342,8772023Assets 2024: $81,128,530Liabilities 2024: $3,347,474Net Assets 2024: $77,781,0562024

Highlighted filing

2024

Assets$81,128,530
Liabilities$3,347,474
Net Assets$77,781,056
Open 2024 Filing

Operations Trend

Revenue Growth98th percentile

Revenue, expenses, and net income across loaded years, with this filing highlighted.

$40M$30M$20M$10M$0-$10MExpenses 2010: $2,263,8742010Revenue 2011: $1,054,718Expenses 2011: $2,129,907Net Income 2011: -$1,075,1892011Expenses 2012: $2,039,6442012Expenses 2013: $2,040,1512013Revenue 2014: $5,921,552Expenses 2014: $1,989,408Net Income 2014: $3,932,1442014Revenue 2015: $1,845,392Expenses 2015: $1,954,957Net Income 2015: -$109,5652015Revenue 2016: $36,568,950Expenses 2016: $1,997,694Net Income 2016: $34,571,2562016Revenue 2017: $2,547,864Expenses 2017: $2,048,992Net Income 2017: $498,8722017Revenue 2018: $2,635,201Expenses 2018: $2,254,734Net Income 2018: $380,4672018Revenue 2019: $2,558,906Expenses 2019: $2,427,191Net Income 2019: $131,7152019Revenue 2020: $12,959,074Expenses 2020: $2,328,525Net Income 2020: $10,630,5492020Revenue 2021: $2,931,752Expenses 2021: $2,412,456Net Income 2021: $519,2962021Revenue 2022: $2,523,586Expenses 2022: $2,278,521Net Income 2022: $245,0652022Revenue 2023: $1,586,292Expenses 2023: $2,508,519Net Income 2023: -$922,2272023Revenue 2024: $7,128,753Expenses 2024: $2,624,935Net Income 2024: $4,503,8182024

Highlighted filing

2024

Revenue$7,128,753
Expenses$2,624,935
Net Income$4,503,818
Open 2024 Filing
Jump To
Filing Snapshot
Filing Period
Jul 1, 2023 to Jun 30, 2024
Signed
Apr 22, 2025
Return Version
2023v6.0
Gross Receipts
$20,995,767
Mission and Program Overview

Mission

The biotechnology greenhouse of southeastern pennsylvania was established with funds from the commonwealth of pennsylvania's share of the national tobacco settlement to accelerate growth of the life sciences industry by transforming the southeast pennsylvania region's strength in biomedical research and development into commercial opportunities. Approximately $25 million of the original government grant funding has been dedicated for pre-seed or "gap" funding for promising therapeutic, biomedical device and related technology companies, in a program called the greenhouse fund. The greenhouse fund is designed to move promising scientific projects out of the laboratory and into commercial opportunities. Additional funds were set aside for initiatives to increase the region's strengths in biomedical informatics and clinical trials.

Bioadvance was established in 2001 as one of three life sciences greenhouses funded with a share of pennsylvania's national tobacco settlement revenues, to promote human health by supporting biomedical innovation in the southeastern pa region. Bioadvance dedicated $25 million of the original grant funding for pre-seed and early-stage funding to help move technologies to the next stage of development and to support the initiatives intended to increase the region's strength in biomedical informatics and clinical trials. Since the original grant funding was expended, bioadvance continues to support emerging life sciences companies in southeastern pa and the surrounding mid-atlantic region that are focused on technologies to improve human health. As of june 30, 2024, a total of $72.7 million has been invested by bioadvance in 114 companies and academic technologies.

Balance Sheet Detail
LineBeginningEndChange
Assets
Investments Program Related$37,436,064$40,700,568▲ $3,264,504
Investments in Publicly Traded Securities$26,908,073$24,252,137▼ $2,655,936
Savings and Temporary Cash Investments$17,037,823$15,091,118▼ $1,946,705
Prepaid Expenses and Deferred Charges$366,043$267,345▼ $98,698
Land, Buildings, and Equipment, Net$6,442$84,747▲ $78,305
Cash and Non-Interest-Bearing Accounts$6,824$6,824→ $0
Total Assets$81,948,557$81,128,530▼ $820,027
Other Assets Total$187,288$725,791▲ $538,503
Liabilities
Deferred Revenue$4,067,595$2,224,446▼ $1,843,149
Other Liabilities$188,995$745,324▲ $556,329
Accounts Payable and Accrued Expenses$349,090$377,704▲ $28,614
Total Liabilities$4,605,680$3,347,474▼ $1,258,206
Net Assets / Fund Balance
Net Assets Without Donor Restrictions$77,342,877$77,781,056▲ $438,179
Total Net Assets Fund Balance$77,342,877$77,781,056▲ $438,179
Total Liabilities and Net Assets / Fund Balance$81,948,557$81,128,530▼ $820,027

Asset Categories

AssetBook ValueDepreciationBasis
Buildings$75,855$50,418$126,273
Leasehold Improvements$8,892$126$9,018
Investment Program Related Org$6,320,836--
Compensation and Service Providers
Top Officer Pay58th percentile

Employees

NameTitleFull / Part TimeBaseOtherTotal
Frederick JonesVP (secretary Thru 6/1/24)FT$302,884$102,359$405,243
Shahram HejaziCEO & Managing DirectorPT$301,683$102,794$404,477
Robert DriscollDirector of FinanceFT$205,311$65,643$270,954
Greg HarrimanVP and Asst SecretaryPT$187,540$37,703$225,243
Marnie MccoyProgram DirectorFT$128,321$29,630$157,951
David ShinCOO and Secretary (eff 6/6/24)FT$23,333-$23,333

Board Members and Trustees

NameTitle
Barbara S SchilbergDirector
Jen GilburgDirector
Lauren LenfestDirector
Philip Gerbino PharmdDirector
Steven Nichtberger MdDirector
Roy M RosinDirector (eff 2/24)
J Larry Jamison Md PhdDirector (thru 12/23)
John GillDirector (thru 2/24)
Revenue and Support

Revenue Composition

Contributions and Grants
$2,843,149
Program Service Revenue
$1,876,935
Investment Income
$2,096,402
Other Revenue
$312,267
Change in Net Assets
$4,503,818

Audited Revenue Reconciliation

Revenue per Audited Statements
$5,180,968
Revenue Not Reported on Financial Statements
$1,947,785
Revenue Not Reported on Form 990
$0
Other Revenue Adjustments
$1,947,785
Total Revenue per Audited Statements
$5,180,968
Total Revenue per Form 990
$7,128,753
Expenses and Functional Allocation

Major Expense Lines

Line ItemAmount
Salaries, Compensation, and Employee Benefits$1,831,098
Other Expenses$793,837
Grants and Similar Amounts Paid$0
Professional Fundraising Fees$0
Total Fundraising Expense$0

Functional Expense Allocation

Line ItemProgramManagementFundraisingTotal
Current Officers, Directors, Trustees, and Key Employees$1,134,884$82,500-$1,217,384
Other Salaries and Wages$185,106$283,636-$468,742
Occupancy-$223,025-$223,025
Fees for Services Other$157,193$48,699-$205,892
Payroll Taxes$62,855$18,775-$81,630
Insurance-$73,200-$73,200
Fees for Services Legal$25,121$44,204-$69,325
Other Employee Benefits$27,472$23,963-$51,435
Fees for Services Accounting-$49,200-$49,200
Information Technology-$35,123-$35,123
Office Expenses-$15,299-$15,299
Pension Plan Contributions$4,997$6,910-$11,907
Other Expenses$58,092$8,565-$8,565
Travel-$8,250-$8,250
All Other Expenses$1,349$6,431-$7,780
Depreciation Depletion-$6,678-$6,678
Conferences and Meetings-$4,419-$4,419
Total Functional Expenses$1,657,069$967,866$0$2,624,935

Audited Expense Reconciliation

Line ItemAmount
Expenses per Audited Statements$2,624,935
Total Expenses per Audited Statements$2,624,935
Total Expenses per Form 990$2,624,935
Expenses Not Reported on Financial Statements$0
Expenses Not Reported on Form 990$0
Fundraising, Events, and Gaming
Fundraising activities
No
Gaming activities
No
Professional fundraiser used
No

Fundraising and Gaming Totals

Line ItemAmount
Professional Fundraising Fees$0
Political and Lobbying Activity
Political campaign activity
No
Lobbying activity
Yes
Subject to proxy tax
No
Debt and Bond Financing

Other Reported Liabilities

LiabilityAmount
Lease Liability$745,324
Governance and Compliance

Governance Checklist

Compiled or reviewed by an accountant
No
Annual disclosure for covered persons
Yes
Audit committee
Yes
Backup withholding compliance
Yes
Business relationship with 35% controlled entity
No
Business relationship with family members
No
Business relationship with organization members
No
Material changes to governing documents
No
Compensation from other sources disclosed
No
CEO compensation reviewed
Yes
Other officer compensation reviewed
Yes
Conflict-of-interest policy
Yes
Audited financial statements prepared
No
Key decisions subject to board approval
No
Management duties delegated
No

Governance Explanations

Form 990, Part VI, Section B, Line 11B

“Before the form 990 is filed with the irs, the form is distributed to the organization's board of directors for their review and comments.”

Form 990, Part VI, Section B, Line 12C

“Periodically, the organization has its employees and board of directors sign a conflict of interest statement.”

Form 990, Part VI, Section B, Line 15

“Bioadvance recommended to the organization's compensation committee of the board of directors the salary increase for its ceo and officers for the year. After review and discussion, the compensation committee of the board of directors determined the appropriate salary increases.”

Form 990, Part VI, Section C, Line 19

“The organization's governing documents, conflict of interest policy and financial statements are available upon request.”

Filing and Contact Details

Filer

Filer Name
Bioadvance Capital
EIN
46-0481876
Phone
6102300536
Address
101 WEST ELM STREET 330, CONSHOHOCKEN, PA 19428

Signing Officer

Name
Shahram Hejazi
Title
CEO & Managing Director
Phone
6102300536
Signed
2025-04-22
Discuss with paid preparer
Yes

Organization Details

Principal Officer
Shahram Hejazi
Formed
2002
Legal Domicile
Pa
Voting Board Members
7
Independent Board Members
6
Employees
6
Volunteers
8

Preparer

Firm
Eisner Advisory Group LLC
Address
130 NORTH 18TH STREET SUITE 3000, PHILADELPHIA, PA 19103-2757
Preparer
Helen M Martin
Phone
2158818800
Supplemental Narrative

Additional Explanations

FORM 990, PART XI, LINE 9:

“Unrealized loss on portfolio investments -4,677,992.”

Financial Statement Notes

PART X, LINE 2:

“The internal revenue service has classified bioadvance as exempt from federal income taxes under section 501(c)(3) of the internal revenue code. U.s. Gaap requires management to evaluate tax positions taken and recognize a tax liability, if bioadvance has taken an uncertain tax position that more likely than not would not be sustained upon examination by a government authority. Management has analyzed the tax positions taken by bioadvance and has concluded that as of june 30, 2024 and 2023, there are no uncertain tax positions taken or expected to be taken that would require recognition of a liability or disclosure in the consolidated financial statements. Bioadvance recognizes interest and penalties associated with income taxes, if any, as part of interest and administrative expenses. No income tax-related interest and penalties were recorded for either of the years ended june 30, 2024 or 2023.”

PART XI, LINE 4B - OTHER ADJUSTMENTS:

“Realized gain/loss on cash investments 70,850. Realized gain/loss on portfolio investments 1,876,935.”

Raw XML AppendixShowing 400 of 645 raw XML fields

This appendix keeps the raw XML leaves available for debugging and edge-case review. The human report above is the primary experience.

Path#Value
IRS990/AccountantCompileOrReviewInd00
IRS990/AccountsPayableAccrExpnssGrp/BOYAmt0349090
IRS990/AccountsPayableAccrExpnssGrp/EOYAmt0377704
IRS990/ActivitiesConductedPrtshpInd00
IRS990/ActivityOrMissionDesc0BIOADVANCE WAS ESTABLISHED IN 2001 AS ONE OF THREE LIFE SCIENCES GREENHOUSES FUNDED WITH A SHARE OF PENNSYLVANIA'S NATIONAL TOBACCO SETTLEMENT REVENUES, TO PROMOTE HUMAN HEALTH BY SUPPORTING BIOMEDICAL INNOVATION IN THE SOUTHEASTERN PA REGION. BIOADVANCE DEDICATED $25 MILLION OF THE ORIGINAL GRANT FUNDING FOR PRE-SEED AND EARLY-STAGE FUNDING TO HELP MOVE TECHNOLOGIES TO THE NEXT STAGE OF DEVELOPMENT AND TO SUPPORT THE INITIATIVES INTENDED TO INCREASE THE REGION'S STRENGTH IN BIOMEDICAL INFORMATICS AND CLINICAL TRIALS. SINCE THE ORIGINAL GRANT FUNDING WAS EXPENDED, BIOADVANCE CONTINUES TO SUPPORT EMERGING LIFE SCIENCES COMPANIES IN SOUTHEASTERN PA AND THE SURROUNDING MID-ATLANTIC REGION THAT ARE FOCUSED ON TECHNOLOGIES TO IMPROVE HUMAN HEALTH. AS OF JUNE 30, 2024, A TOTAL OF $72.7 MILLION HAS BEEN INVESTED BY BIOADVANCE IN 114 COMPANIES AND ACADEMIC TECHNOLOGIES.
IRS990/AddressChangeInd0X
IRS990/AllOtherExpensesGrp/ManagementAndGeneralAmt06431
IRS990/AllOtherExpensesGrp/ProgramServicesAmt01349
IRS990/AllOtherExpensesGrp/TotalAmt07780
IRS990/AnnualDisclosureCoveredPrsnInd01
IRS990/AuditCommitteeInd01
IRS990/BackupWthldComplianceInd01
IRS990/BooksInCareOfDetail/BusinessName/BusinessNameLine1Txt0ROBERT DRISCOLL DIRECTOR OF FINANCE
IRS990/BooksInCareOfDetail/PhoneNum06102300536
IRS990/BooksInCareOfDetail/USAddress/AddressLine1Txt0101 WEST ELM STREET SUITE 330
IRS990/BooksInCareOfDetail/USAddress/CityNm0CONSHOHOCKEN
IRS990/BooksInCareOfDetail/USAddress/StateAbbreviationCd0PA
IRS990/BooksInCareOfDetail/USAddress/ZIPCd019428
IRS990/BusinessRlnWith35CtrlEntInd00
IRS990/BusinessRlnWithFamMemInd00
IRS990/BusinessRlnWithOrgMemInd00
IRS990/CashNonInterestBearingGrp/BOYAmt06824
IRS990/CashNonInterestBearingGrp/EOYAmt06824
IRS990/ChangeToOrgDocumentsInd00
IRS990/CntrctRcvdGreaterThan100KCnt00
IRS990/CollectionsOfArtInd00
IRS990/CompCurrentOfcrDirectorsGrp/ManagementAndGeneralAmt082500
IRS990/CompCurrentOfcrDirectorsGrp/ProgramServicesAmt01134884
IRS990/CompCurrentOfcrDirectorsGrp/TotalAmt01217384
IRS990/CompensationFromOtherSrcsInd00
IRS990/CompensationProcessCEOInd01
IRS990/CompensationProcessOtherInd01
IRS990/ConferencesMeetingsGrp/ManagementAndGeneralAmt04419
IRS990/ConferencesMeetingsGrp/TotalAmt04419
IRS990/ConflictOfInterestPolicyInd01
IRS990/ConservationEasementsInd00
IRS990/ConsolidatedAuditFinclStmtInd00
IRS990/CreditCounselingInd00
IRS990/CYBenefitsPaidToMembersAmt00
IRS990/CYContributionsGrantsAmt02843149
IRS990/CYGrantsAndSimilarPaidAmt00
IRS990/CYInvestmentIncomeAmt02096402
IRS990/CYOtherExpensesAmt0793837
IRS990/CYOtherRevenueAmt0312267
IRS990/CYProgramServiceRevenueAmt01876935
IRS990/CYRevenuesLessExpensesAmt04503818
IRS990/CYSalariesCompEmpBnftPaidAmt01831098
IRS990/CYTotalExpensesAmt02624935
IRS990/CYTotalFundraisingExpenseAmt00
IRS990/CYTotalProfFndrsngExpnsAmt00
IRS990/CYTotalRevenueAmt07128753
IRS990/DecisionsSubjectToApprovaInd00
IRS990/DeductibleArtContributionInd00
IRS990/DeductibleNonCashContriInd00
IRS990/DeferredRevenueGrp/BOYAmt04067595
IRS990/DeferredRevenueGrp/EOYAmt02224446
IRS990/DelegationOfMgmtDutiesInd00
IRS990/DepreciationDepletionGrp/ManagementAndGeneralAmt06678
IRS990/DepreciationDepletionGrp/TotalAmt06678
IRS990/Desc0GREENHOUSE PROGRAM - THE CORNERSTONE OF BIOADVANCE INVESTMENT ACTIVITIES - WAS LAUNCHED TWO MONTHS AFTER RECEIVING THE DCED GRANT. THE PROGRAM FUNDS YOUNG COMPANIES FOR RESEARCH, DEVELOPMENT AND COMMERCIALIZATION ACTIVITIES THAT WILL PROVIDE ENOUGH PROGRESS TO ENABLE THEM TO ATTRACT VENTURE CAPITAL OR AN INDUSTRY PARTNER. INDIVIDUAL COMPANIES ARE ELIGIBLE TO RECEIVE UP TO $1,500,000 WHICH OFTEN IS DISBURSED AS MILESTONES ARE ACHIEVED, UNLESS THE CAP IS INCREASED BY THE BOARD. THE INVESTMENTS ARE IN THE FORM OF EQUITY OR A NOTE THAT CONVERTS INTO EQUITY UPON A SPECIFIED MINIMUM SIZE OF DOLLAR FUNDING.
IRS990/DescribedInSection501c3Ind01
IRS990/DisregardedEntityInd00
IRS990/DocumentRetentionPolicyInd01
IRS990/DonorAdvisedFundInd00
IRS990/DonorRstrOrQuasiEndowmentsInd00
IRS990/ElectionOfBoardMembersInd00
IRS990/EmployeeCnt06
IRS990/EmploymentTaxReturnsFiledInd01
IRS990/EngagedInExcessBenefitTransInd00
IRS990/ExpenseAmt01657069
IRS990/FamilyOrBusinessRlnInd00
IRS990/FederalGrantAuditRequiredInd00
IRS990/FeesForServicesAccountingGrp/ManagementAndGeneralAmt049200
IRS990/FeesForServicesAccountingGrp/TotalAmt049200
IRS990/FeesForServicesLegalGrp/ManagementAndGeneralAmt044204
IRS990/FeesForServicesLegalGrp/ProgramServicesAmt025121
IRS990/FeesForServicesLegalGrp/TotalAmt069325
IRS990/FeesForServicesOtherGrp/ManagementAndGeneralAmt048699
IRS990/FeesForServicesOtherGrp/ProgramServicesAmt0157193
IRS990/FeesForServicesOtherGrp/TotalAmt0205892
IRS990/ForeignActivitiesInd00
IRS990/ForeignFinancialAccountInd00
IRS990/ForeignOfficeInd00
IRS990/Form8282PropertyDisposedOfInd00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt032.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt10.50
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt20.50
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt30.50
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt40.50
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt50.50
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt60.50
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt70.50
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt80.50
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt940.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt1024.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt1140.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt1240.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt1340.00
IRS990/Form990PartVIISectionAGrp/HighestCompensatedEmployeeInd0X
IRS990/Form990PartVIISectionAGrp/HighestCompensatedEmployeeInd1X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd0X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd1X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd2X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd3X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd4X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd5X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd6X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd7X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd8X
IRS990/Form990PartVIISectionAGrp/OfficerInd0X
IRS990/Form990PartVIISectionAGrp/OfficerInd1X
IRS990/Form990PartVIISectionAGrp/OfficerInd2X
IRS990/Form990PartVIISectionAGrp/OfficerInd3X
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt058104
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt10
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt20
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt30
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt40
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt50
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt60
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt70
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt80
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt957289
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt1010143
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt110
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt1245343
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt1316830
IRS990/Form990PartVIISectionAGrp/PersonNm0SHAHRAM HEJAZI
IRS990/Form990PartVIISectionAGrp/PersonNm1JEN GILBURG
IRS990/Form990PartVIISectionAGrp/PersonNm2PHILIP GERBINO PHARMD
IRS990/Form990PartVIISectionAGrp/PersonNm3JOHN GILL
IRS990/Form990PartVIISectionAGrp/PersonNm4ROY M ROSIN
IRS990/Form990PartVIISectionAGrp/PersonNm5LAUREN LENFEST
IRS990/Form990PartVIISectionAGrp/PersonNm6STEVEN NICHTBERGER MD
IRS990/Form990PartVIISectionAGrp/PersonNm7BARBARA S SCHILBERG
IRS990/Form990PartVIISectionAGrp/PersonNm8J LARRY JAMISON MD PHD
IRS990/Form990PartVIISectionAGrp/PersonNm9FREDERICK JONES
IRS990/Form990PartVIISectionAGrp/PersonNm10GREG HARRIMAN
IRS990/Form990PartVIISectionAGrp/PersonNm11DAVID SHIN
IRS990/Form990PartVIISectionAGrp/PersonNm12ROBERT DRISCOLL
IRS990/Form990PartVIISectionAGrp/PersonNm13MARNIE MCCOY
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt0346373
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt10
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt20
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt30
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt40
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt50
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt60
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt70
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt80
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt9347954
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt10215100
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt1123333
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt12225611
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt13141121
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt00
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt10
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt20
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt30
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt40
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt50
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt60
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt70
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt80
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt90
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt100
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt110
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt120
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt130
IRS990/Form990PartVIISectionAGrp/TitleTxt0CEO & MANAGING DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt1DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt2DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt3DIRECTOR (THRU 2/24)
IRS990/Form990PartVIISectionAGrp/TitleTxt4DIRECTOR (EFF 2/24)
IRS990/Form990PartVIISectionAGrp/TitleTxt5DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt6DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt7DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt8DIRECTOR (THRU 12/23)
IRS990/Form990PartVIISectionAGrp/TitleTxt9VP (SECRETARY THRU 6/1/24)
IRS990/Form990PartVIISectionAGrp/TitleTxt10VP AND ASST SECRETARY
IRS990/Form990PartVIISectionAGrp/TitleTxt11COO AND SECRETARY (EFF 6/6/24)
IRS990/Form990PartVIISectionAGrp/TitleTxt12DIRECTOR OF FINANCE
IRS990/Form990PartVIISectionAGrp/TitleTxt13PROGRAM DIRECTOR
IRS990/Form990ProvidedToGvrnBodyInd01
IRS990/FormationYr02002
IRS990/FormerOfcrEmployeesListedInd00
IRS990/FSAuditedBasisGrp/SeparateBasisFinclStmtInd0X
IRS990/FSAuditedInd01
IRS990/FundraisingActivitiesInd00
IRS990/GainOrLossGrp/SecuritiesAmt070850
IRS990/GamingActivitiesInd00
IRS990/GoverningBodyVotingMembersCnt07
IRS990/GovernmentGrantsAmt02843149
IRS990/GrantsToIndividualsInd00
IRS990/GrantsToOrganizationsInd00
IRS990/GrantToRelatedPersonInd00
IRS990/GrossAmountSalesAssetsGrp/SecuritiesAmt013937864
IRS990/GrossReceiptsAmt020995767
IRS990/GroupReturnForAffiliatesInd00
IRS990/IncludeFIN48FootnoteInd01
IRS990/IndependentAuditFinclStmtInd01
IRS990/IndependentVotingMemberCnt06
IRS990/IndivRcvdGreaterThan100KCnt05
IRS990/IndoorTanningServicesInd00
IRS990/InfoInScheduleOPartIIIInd0X
IRS990/InfoInScheduleOPartVIInd0X
IRS990/InfoInScheduleOPartXIInd0X
IRS990/InformationTechnologyGrp/ManagementAndGeneralAmt035123
IRS990/InformationTechnologyGrp/TotalAmt035123
IRS990/InsuranceGrp/ManagementAndGeneralAmt073200
IRS990/InsuranceGrp/TotalAmt073200
IRS990/InvestmentIncomeGrp/ExclusionAmt01598308
IRS990/InvestmentIncomeGrp/RelatedOrExemptFuncIncomeAmt0427244
IRS990/InvestmentIncomeGrp/TotalRevenueColumnAmt02025552
IRS990/InvestmentInJointVentureInd00
IRS990/InvestmentsProgramRelatedGrp/BOYAmt037436064
IRS990/InvestmentsProgramRelatedGrp/EOYAmt040700568
IRS990/InvestmentsPubTradedSecGrp/BOYAmt026908073
IRS990/InvestmentsPubTradedSecGrp/EOYAmt024252137
IRS990/IRPDocumentCnt011
IRS990/IRPDocumentW2GCnt00
IRS990/LandBldgEquipAccumDeprecAmt050544
IRS990/LandBldgEquipBasisNetGrp/BOYAmt06442
IRS990/LandBldgEquipBasisNetGrp/EOYAmt084747
IRS990/LandBldgEquipCostOrOtherBssAmt0135291
IRS990/LegalDomicileStateCd0PA
IRS990/LessCostOthBasisSalesExpnssGrp/SecuritiesAmt013867014
IRS990/LoanOutstandingInd00
IRS990/LobbyingActivitiesInd01
IRS990/LocalChaptersInd00
IRS990/MaterialDiversionOrMisuseInd00
IRS990/MembersOrStockholdersInd00
IRS990/MethodOfAccountingAccrualInd0X
IRS990/MinutesOfCommitteesInd01
IRS990/MinutesOfGoverningBodyInd01
IRS990/MissionDesc0BIOADVANCE WAS ESTABLISHED IN 2001 AS ONE OF THREE LIFE SCIENCES GREENHOUSES FUNDED WITH A SHARE OF PENNSYLVANIA'S NATIONAL TOBACCO SETTLEMENT REVENUES, TO PROMOTE HUMAN HEALTH BY SUPPORTING BIOMEDICAL INNOVATION IN THE SOUTHEASTERN PA REGION. BIOADVANCE DEDICATED $25 MILLION OF THE ORIGINAL GRANT FUNDING FOR PRE-SEED AND EARLY-STAGE FUNDING TO HELP MOVE TECHNOLOGIES TO THE NEXT STAGE OF DEVELOPMENT AND TO SUPPORT THE INITIATIVES INTENDED TO INCREASE THE REGION'S STRENGTH IN BIOMEDICAL INFORMATICS AND CLINICAL TRIALS. SINCE THE ORIGINAL GRANT FUNDING WAS EXPENDED, BIOADVANCE CONTINUES TO SUPPORT EMERGING LIFE SCIENCES COMPANIES IN SOUTHEASTERN PA AND THE SURROUNDING MID-ATLANTIC REGION THAT ARE FOCUSED ON TECHNOLOGIES TO IMPROVE HUMAN HEALTH.
IRS990/MoreThan5000KToIndividualsInd00
IRS990/MoreThan5000KToOrgInd00
IRS990/NameChangeInd0X
IRS990/NetAssetsOrFundBalancesBOYAmt077342877
IRS990/NetAssetsOrFundBalancesEOYAmt077781056
IRS990/NetGainOrLossInvestmentsGrp/ExclusionAmt070850
IRS990/NetGainOrLossInvestmentsGrp/TotalRevenueColumnAmt070850
IRS990/NetUnrelatedBusTxblIncmAmt00
IRS990/NetUnrlzdGainsLossesInvstAmt0612353
IRS990/NoDonorRestrictionNetAssetsGrp/BOYAmt077342877
IRS990/NoDonorRestrictionNetAssetsGrp/EOYAmt077781056
IRS990/NondeductibleContributionsInd00
IRS990/OccupancyGrp/ManagementAndGeneralAmt0223025
IRS990/OccupancyGrp/TotalAmt0223025
IRS990/OfficeExpensesGrp/ManagementAndGeneralAmt015299
IRS990/OfficeExpensesGrp/TotalAmt015299
IRS990/OfficerMailingAddressInd00
IRS990/OperateHospitalInd00
IRS990/Organization501c3Ind0X
IRS990/OrganizationFollowsFASB117Ind0X
IRS990/OtherAssetsTotalGrp/BOYAmt0187288
IRS990/OtherAssetsTotalGrp/EOYAmt0725791
IRS990/OtherChangesInNetAssetsAmt0-4677992
IRS990/OtherEmployeeBenefitsGrp/ManagementAndGeneralAmt023963
IRS990/OtherEmployeeBenefitsGrp/ProgramServicesAmt027472
IRS990/OtherEmployeeBenefitsGrp/TotalAmt051435
IRS990/OtherExpensesGrp/Desc0DATABASE
IRS990/OtherExpensesGrp/Desc1OFFICE RELOCATION EXPEN
IRS990/OtherExpensesGrp/Desc2MEMBERSHIPS
IRS990/OtherExpensesGrp/Desc3SPONSORSHIPS
IRS990/OtherExpensesGrp/ManagementAndGeneralAmt016944
IRS990/OtherExpensesGrp/ManagementAndGeneralAmt112045
IRS990/OtherExpensesGrp/ManagementAndGeneralAmt28565
IRS990/OtherExpensesGrp/ProgramServicesAmt058092
IRS990/OtherExpensesGrp/TotalAmt058092
IRS990/OtherExpensesGrp/TotalAmt116944
IRS990/OtherExpensesGrp/TotalAmt212045
IRS990/OtherExpensesGrp/TotalAmt38565
IRS990/OtherLiabilitiesGrp/BOYAmt0188995
IRS990/OtherLiabilitiesGrp/EOYAmt0745324
IRS990/OtherRevenueMiscGrp/BusinessCd0900099
IRS990/OtherRevenueMiscGrp/Desc0BOARD STIPEND
IRS990/OtherRevenueMiscGrp/RelatedOrExemptFuncIncomeAmt02500
IRS990/OtherRevenueMiscGrp/TotalRevenueColumnAmt02500
IRS990/OtherRevenueTotalAmt02500
IRS990/OtherSalariesAndWagesGrp/ManagementAndGeneralAmt0283636
IRS990/OtherSalariesAndWagesGrp/ProgramServicesAmt0185106
IRS990/OtherSalariesAndWagesGrp/TotalAmt0468742
IRS990/PartialLiquidationInd00
IRS990/PayPremiumsPrsnlBnftCntrctInd00
IRS990/PayrollTaxesGrp/ManagementAndGeneralAmt018775
IRS990/PayrollTaxesGrp/ProgramServicesAmt062855
IRS990/PayrollTaxesGrp/TotalAmt081630
IRS990/PensionPlanContributionsGrp/ManagementAndGeneralAmt06910
IRS990/PensionPlanContributionsGrp/ProgramServicesAmt04997
IRS990/PensionPlanContributionsGrp/TotalAmt011907
IRS990/PoliticalCampaignActyInd00
IRS990/PrepaidExpensesDefrdChargesGrp/BOYAmt0366043
IRS990/PrepaidExpensesDefrdChargesGrp/EOYAmt0267345
IRS990/PrincipalOfficerNm0SHAHRAM HEJAZI
IRS990/ProfessionalFundraisingInd00
IRS990/ProgramServiceRevenueGrp/BusinessCd0525990
IRS990/ProgramServiceRevenueGrp/Desc0NET GAIN ON PROGRAM-RELATED INVES
IRS990/ProgramServiceRevenueGrp/RelatedOrExemptFuncIncomeAmt01876935
IRS990/ProgramServiceRevenueGrp/TotalRevenueColumnAmt01876935
IRS990/ProhibitedTaxShelterTransInd00
IRS990/PYBenefitsPaidToMembersAmt00
IRS990/PYContributionsGrantsAmt01352745
IRS990/PYExcessBenefitTransInd00
IRS990/PYGrantsAndSimilarPaidAmt00
IRS990/PYInvestmentIncomeAmt01139187
IRS990/PYOtherExpensesAmt0735743
IRS990/PYOtherRevenueAmt0184883
IRS990/PYProgramServiceRevenueAmt0-1090523
IRS990/PYRevenuesLessExpensesAmt0-922227
IRS990/PYSalariesCompEmpBnftPaidAmt01772776
IRS990/PYTotalExpensesAmt02508519
IRS990/PYTotalProfFndrsngExpnsAmt00
IRS990/PYTotalRevenueAmt01586292
IRS990/QuidProQuoContributionsInd00
IRS990/RcvFndsToPayPrsnlBnftCntrctInd00
IRS990/ReconcilationRevenueExpnssAmt04503818
IRS990/RegularMonitoringEnfrcInd01
IRS990/RelatedEntityInd01
IRS990/RelatedOrganizationCtrlEntInd01
IRS990/ReportInvestmentsOtherSecInd00
IRS990/ReportLandBuildingEquipmentInd01
IRS990/ReportOtherAssetsInd00
IRS990/ReportOtherLiabilitiesInd01
IRS990/ReportProgramRelatedInvstInd01
IRS990/RevenueAmt02613946
IRS990/RoyaltiesRevenueGrp/RelatedOrExemptFuncIncomeAmt0309767
IRS990/RoyaltiesRevenueGrp/TotalRevenueColumnAmt0309767
IRS990/SavingsAndTempCashInvstGrp/BOYAmt017037823
IRS990/SavingsAndTempCashInvstGrp/EOYAmt015091118
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearAmt02843149
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearMinus1YearAmt01352745
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearMinus2YearsAmt01000000
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearMinus3YearsAmt01000765
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearMinus4YearsAmt01241666
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/TotalAmt07438325
IRS990ScheduleA/GrossInvestmentIncome170Grp/CurrentTaxYearAmt02337819
IRS990ScheduleA/GrossInvestmentIncome170Grp/CurrentTaxYearMinus1YearAmt01401187
IRS990ScheduleA/GrossInvestmentIncome170Grp/CurrentTaxYearMinus2YearsAmt0579600
IRS990ScheduleA/GrossInvestmentIncome170Grp/CurrentTaxYearMinus3YearsAmt0879393
IRS990ScheduleA/GrossInvestmentIncome170Grp/CurrentTaxYearMinus4YearsAmt02237090
IRS990ScheduleA/GrossInvestmentIncome170Grp/TotalAmt07435089
IRS990ScheduleA/GrossReceiptsRltdActivitiesAmt02073568
IRS990ScheduleA/PublicOrganization170Ind0X
IRS990ScheduleA/PublicSupportCY170Pct00.50010
IRS990ScheduleA/PublicSupportPY170Pct00.45480
IRS990ScheduleA/PublicSupportTotal170Amt07438325
IRS990ScheduleA/ThirtyThrPctSuprtTestsCY170Ind0X
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearAmt02843149
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearMinus1YearAmt01352745
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearMinus2YearsAmt01000000
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearMinus3YearsAmt01000765
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearMinus4YearsAmt01241666
IRS990ScheduleA/TotalCalendarYear170Grp/TotalAmt07438325
IRS990ScheduleA/TotalSupportAmt014873414
IRS990ScheduleB/ContributorInformationGrp/ContributorBusinessName/BusinessNameLine10RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorNum0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/AddressLine10RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/AddressLine20RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/City0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/State0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/ZIPCode0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/TotalContributionsAmt0RESTRICTED
IRS990/ScheduleBRequiredInd01
IRS990ScheduleC/DirectContactLegislatorsAmt025272
IRS990ScheduleC/DirectContactLegislatorsInd01
IRS990ScheduleC/GrantsOtherOrganizationsInd00
IRS990ScheduleC/MailingsMembersInd00
IRS990ScheduleC/MediaAdvertisementsInd00
IRS990ScheduleC/NotDescribedSection501c3Ind00
IRS990ScheduleC/OtherActivitiesInd00
IRS990ScheduleC/PaidStaffOrManagementInd00
IRS990ScheduleC/PublicationsOrBroadcastInd00
IRS990ScheduleC/RalliesDemonstrationsInd00
IRS990ScheduleC/SupplementalInformationDetail/ExplanationTxt0BIOADVANCE PAID GREENLEE PARTNERS LLC FOR ITS SHARE OF FEES TO MEET WITH STATE LEGISLATORS TO ADVOCATE ON BEHALF OF BIOADVANCE AND TWO OTHER LIFE SCIENCE GREENHOUSES.
IRS990ScheduleC/SupplementalInformationDetail/FormAndLineReferenceDesc0PART II-B, LINE 1:
IRS990ScheduleC/TotalLobbyingExpendituresAmt025272
IRS990ScheduleC/VolunteersInd00
IRS990ScheduleD/BuildingsGrp/BookValueAmt075855
IRS990ScheduleD/BuildingsGrp/DepreciationAmt050418
IRS990ScheduleD/BuildingsGrp/OtherCostOrOtherBasisAmt0126273
IRS990ScheduleD/ExpensesNotReportedAmt00
IRS990ScheduleD/ExpensesNotRptFinclStmtAmt00
IRS990ScheduleD/ExpensesSubtotalAmt02624935
IRS990ScheduleD/FootnoteTextInd0X
IRS990ScheduleD/InvstProgramRelatedOrgGrp/BookValueAmt034354732
IRS990ScheduleD/InvstProgramRelatedOrgGrp/BookValueAmt125000
IRS990ScheduleD/InvstProgramRelatedOrgGrp/BookValueAmt26320836
IRS990ScheduleD/InvstProgramRelatedOrgGrp/Desc0COMMON & PREFERRED INVESTMENTS
IRS990ScheduleD/InvstProgramRelatedOrgGrp/Desc1INVESTMENT IN PLSG ACCELERATOR
IRS990ScheduleD/InvstProgramRelatedOrgGrp/Desc2NOTES RECEIVABLE
IRS990ScheduleD/InvstProgramRelatedOrgGrp/MethodValuationCd0F
IRS990ScheduleD/InvstProgramRelatedOrgGrp/MethodValuationCd1F
IRS990ScheduleD/InvstProgramRelatedOrgGrp/MethodValuationCd2F
IRS990ScheduleD/LeaseholdImprovementsGrp/BookValueAmt08892
IRS990ScheduleD/LeaseholdImprovementsGrp/DepreciationAmt0126
IRS990ScheduleD/LeaseholdImprovementsGrp/OtherCostOrOtherBasisAmt09018
IRS990ScheduleD/OtherLiabilitiesOrgGrp/Amt0745324
IRS990ScheduleD/OtherLiabilitiesOrgGrp/Desc0LEASE LIABILITY

Document Assets

No mirrored PDF or thumbnail assets are attached yet.

Filings

Displayed year

2024 • Form 990Detailed filing. Detailed filing data is available for this year.

Open filing
Assets
$81,128,530
Liabilities
$3,347,474
Net assets
$77,781,056
Revenue
$7,128,753
Expenses
$2,624,935
Net income
$4,503,818
Balance SheetOperations
YearAssetsLiabilitiesNet AssetsRevenueExpensesNet Income
2024Detailed filing. Detailed filing data is available for this year.$81.1$3.35$77.8$7.13$2.62$4.50
2023Summary only. Only limited summary data is available for this year.$81.9$4.61$77.3$1.59$2.51$0.92
2022Summary only. Only limited summary data is available for this year.$73.1$0.30$72.8$2.52$2.28$0.25
2021Summary only. Only limited summary data is available for this year.$80.2$0.42$79.8$2.93$2.41$0.52
2020Summary only. Only limited summary data is available for this year.$78.6$0.65$77.9$13.0$2.33$10.6
2019Summary only. Only limited summary data is available for this year.$66.0$0.61$65.4$2.56$2.43$0.13
2018Summary only. Only limited summary data is available for this year.$60.3$0.64$59.7$2.64$2.25$0.38
2017Summary only. Only limited summary data is available for this year.$61.0$0.61$60.4$2.55$2.05$0.50
2016Summary only. Only limited summary data is available for this year.$61.4$0.61$60.8$36.6$2.00$34.6
2015Summary only. Only limited summary data is available for this year.$29.0$0.28$28.7$1.85$1.95$0.11
2014Summary only. Only limited summary data is available for this year.$31.6$0.47$31.1$5.92$1.99$3.93
2013Summary only. Only limited summary data is available for this year.$26.6$0.32$26.3$2.04
2012Summary only. Only limited summary data is available for this year.$25.6$0.54$25.1$2.04
2011Summary only. Only limited summary data is available for this year.$27.0$0.36$26.6$1.05$2.13$1.08
2010Summary only. Only limited summary data is available for this year.$27.7$0.48$27.3$2.26